申请人:Martin R. Billy
公开号:US20070037890A1
公开(公告)日:2007-02-15
Compounds of the formula:
wherein R, R1 and R4 are defined in the specification, and pharmaceutically acceptable salts, esters and tautomers thereof, having activity at peripheral cannabinoid receptors, commonly designated the CB2 receptor class. The compounds are useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease.
该公式化合物的化学式为:其中R、R1和R4在说明书中有定义,其药物可接受的盐、酯和互变异构体在外周大麻素受体(通常称为CB2受体类)具有活性。该化合物在治疗方面有用,特别是在治疗疼痛、炎症和自身免疫疾病方面。